John C. Kramer
Impact in
- Toxicology top 2%
- Forensic Toxicology and Drug Analysis
- Clinical Psychology top 5%
- Family and Disability Support Research
Papers in
-
- Family and Disability Support Research 10
- Psychedelics and Drug Studies 5
- Co-authors
- Tamar Heller (4 shared papers)Donald F. Klein (4 shared papers)Max Fink (3 shared papers)Joy Hammel (2 shared papers)Catherine K. Arnold (1 shared paper)Jessica M. Kramer (2 shared papers)Jan Mutchler (2 shared papers)Caitlin Coyle (3 shared papers)
- Journals
- Intellectual and developmental disabilities (4 papers)JAMA (4 papers)Journal of Psychoactive Drugs (3 papers)Journal of Drug Issues (3 papers)Journal of Applied Research in Intellectual Disabilities (2 papers)
- Partner nations
- United StatesAustraliaSouth Sudan
In The Last Decade
John C. Kramer
49 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 126
- Toxicology 88
- Clinical Psychology 469
- Safety Research 173
- Cellular and Molecular Neuroscience 306
- Psychiatry and Mental health 194
Countries citing papers authored by John C. Kramer
This map shows the geographic impact of John C. Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Kramer more than expected).
Fields of papers citing papers by John C. Kramer
This network shows the impact of papers produced by John C. Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Kramer. The network helps show where John C. Kramer may publish in the future.
Co-authors
The 25 scholars most cited alongside John C. Kramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1967 | 240 | |
| 2 | 2009 | 138 | |
| 3 | 1967 | 138 | |
| 4 | 1961 | 87 | |
| 5 | 2012 | 85 | |
| 6 | 2010 | 65 | |
| 7 | 2014 | 50 | |
| 8 | 2013 | 50 | |
| 9 | 2008 | 46 | |
| 10 | 1998 | 43 | |
| 11 | 1965 | 39 | |
| 12 | 1992 | 39 | |
| 13 | Clinical efficacy of chlorpromazine-procyclidine combination, imipramine and placebo in depressive disorders. | 1965 | 38 |
| 14 | 2016 | 38 | |
| 15 | 1969 | 34 | |
| 16 | 2009 | 32 | |
| 17 | 1984 | 29 | |
| 18 | 1968 | 23 | |
| 19 | 1977 | 21 | |
| 20 | 2010 | 19 |
About John C. Kramer
John C. Kramer is a scholar working on Clinical Psychology, Sociology and Political Science, Psychiatry and Mental health, Pharmacology and General Health Professions, having authored 52 papers that have together received 1.5k indexed citations. Recurring topics across this work include Family and Disability Support Research (10 papers), Psychedelics and Drug Studies (5 papers), Forensic Toxicology and Drug Analysis (4 papers), Disability Education and Employment (4 papers), Autism Spectrum Disorder Research (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Retirement, Disability, and Employment (3 papers) and Mental Health and Patient Involvement (3 papers). The work is most often cited by research in Toxicology (88 citations), Clinical Psychology (469 citations), Safety Research (173 citations), Cellular and Molecular Neuroscience (306 citations) and Psychiatry and Mental health (194 citations). John C. Kramer has collaborated with scholars based in United States, Australia and South Sudan. Frequent co-authors include Tamar Heller, Donald F. Klein, Max Fink, Joy Hammel, Catherine K. Arnold, Jessica M. Kramer, Jan Mutchler, Caitlin Coyle, Allison Cohen Hall and Ariella Meltzer. Their work appears in journals such as Intellectual and developmental disabilities, JAMA, Journal of Psychoactive Drugs, Journal of Drug Issues and Journal of Applied Research in Intellectual Disabilities.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.